Barco’s Coronis Uniti display system had previously been cleared for viewing PACS and mammography images, including breast tomosynthesis. The FDA’s new indications for use include breast MRI, breast ultrasound, CT and ultrasound, including vascular and gynecological ultrasound, enabling radiologists to view a host of breast imaging modalities – in color or grayscale, 2D or 3D, static or dynamic – on a single display.
The ability to access any image on a single display offers significant benefits, from workflow and clinical perspectives. First of all, it eliminates the need to change workstations to complete patient studies. Additionally, running side-by-side comparisons and image fusions have proven to positively impact diagnostic interpretation. The use of ultrasound in combination with conventional mammography in women with dense breasts, for example, has resulted in better early breast cancer detection.(1)
“To maximize the diagnostic value of color breast images, we developed new technologies to calibrate and maintain the consistency of these color images” adds Lynda Domogalla, “and we are leading in the definition of a Color Standard Display Function (CSDF) to ensure the accuracy and consistency of color images on diagnostic displays.”
Barco also found a way to counteract motion blur when reviewing multi-frame image sequences such as digital breast tomosynthesis, breast ultrasound and breast MRI. Thanks to RapidFrameTM technology – which provides a high pixel refresh rate – Coronis Uniti enables radiologists to accurately visualize moving and changing images, avoiding loss of detail when scrolling through the 3D stack and ensuring efficient diagnosis as well as swift workflow.